Latest Boehringer Ingelheim Stories
-- In a two-year study, empagliflozin as add-on to metformin demonstrated significantly greater decreases in A1C (blood glucose), body weight and blood pressure compared with glimepiride as add-on
- For those taking metformin, empagliflozin/linagliptin combination tablet showed statistically significant reductions in blood glucose vs.
As Flood Law Group continues to investigate Pradaxa lawsuits, the company Boehringer Ingelheim has just paid $650 million to settle thousands of lawsuits against the drug company, according to
Today most medicines are produced biotechnologically.
The Long Island, New York law firm of Rudolph F. X. Migliore, P. C.
A recent settlement announcement involving Pradaxa has been announced by the manufacture, Boehringer Ingelheim. Toledo, Ohio (PRWEB) June 05, 2014 Boehringer
German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle thousands of claims against the drug manufacturer for injuries and deaths caused by the blood thinner Pradaxa.
Greg Coleman Law reviews the impact of Boehringer’s settlement offer and the drugmaker’s motivations in light of the more than 4,000 pending Pradaxa lawsuits in U.S.
Boehringer Ingelheim Agrees to Pay $650 Million To Settle 4,000 Pradaxa Lawsuit That Allege Internal Bleeding After Taking The Prescription Medication. Columbus,
Boehringer Ingelheim agrees to pay $650 Million to compensate the nearly 4,000 individuals who allege they were injured as a result of Pradaxa usage. CHICAGO, May 29, 2014 /PRNewswire/
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.